Morgan Stanley analyst Carlos De Alba lowered the firm’s price target on Nucor (NUE) to $164 from $167 and keeps an Overweight rating on the shares after updating estimates for the latest company guidance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUE:
- Nucor upgraded to Buy from Neutral at UBS on recent selloff
- Nucor upgraded to Buy from Neutral at UBS
- Positive Outlook on Nucor Despite EPS Guidance Miss: Buy Rating Maintained Due to Strong Capital Returns and Strategic Positioning
- Closing Bell Movers: Nike falls to pandemic onset lows as guidance disappoints
- Nucor sees Q1 EPS 50c-60c, consensus $1.05